logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Morphoceuticals Raises $8 Million To Advance Electroceutical Approach To Regenerative Medicine

Feb 15, 2023•almost 3 years ago

Amount Raised

$8 Million

MedfordBiotechnology

Investors

JuvenescencePrime Movers Lab

Description

Morphoceuticals Inc., a biotechnology company, announced it closed an $8 million Seed-2 funding round led by Prime Movers Lab and initial investor Juvenescence. Morphoceuticals is pioneering the use of artificial intelligence-guided electroceuticals to regenerate limbs, repair tissues, and regenerate organs, leveraging the groundbreaking work of Professors Michael Levin and David Kaplan from Tufts University.

Company Information

Company

Morphoceuticals

Location

Medford, Massachusetts, United States

About

Morphoceuticals is a new biotech company creating the first map of the druggable bioelectrome. By using multi-omics, bioelectric profiling and AI, we aim to exploit the electrical network controlling tissue repair and organ regeneration that exists throughout our bodies.

Related People

2 contacts

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers